PG9 is the founder member of an expanding family of glycandependent human antibodies that preferentially bind the HIV (HIV-1) envelope (Env) glycoprotein (gp) trimer and broadly neutralize the virus. Here, we show that a soluble SOSIP.664 gp140 trimer constructed from the Clade A BG505 sequence binds PG9 with high affinity (∼11 nM), enabling structural and biophysical characterizations of the PG9:Env trimer complex. The BG505 SOSIP.664 gp140 trimer is remarkably stable as assessed by electron microscopy (EM) and differential scanning calorimetry. EM, small angle X-ray scattering, size exclusion chromatography with inline multiangle light scattering and isothermal titration calorimetry all indicate that only a single PG9 fragment antigen-binding (Fab) binds to the Env trimer. An ∼18 Å EM reconstruction demonstrates that PG9 recognizes the trimer asymmetrically at its apex via contact with two of the three gp120 protomers, possibly contributing to its reported preference for a quaternary epitope. Molecular modeling and isothermal titration calorimetry binding experiments with an engineered PG9 mutant suggest that, in addition to the N156 and N160 glycan interactions observed in crystal structures of PG9 with a scaffolded V1/V2 domain, PG9 makes secondary interactions with an N160 glycan from an adjacent gp120 protomer in the antibody-trimer complex. Together, these structural and biophysical findings should facilitate the design of HIV-1 immunogens that possess all elements of the quaternary PG9 epitope required to induce broadly neutralizing antibodies against this region. R ational immunogen design is an increasingly promising approach for development of an effective human immunodeficiency virus-1 (HIV-1) vaccine. The recent discovery of many new and potent broadly neutralizing antibodies (bnAbs) has helped define conserved sites of vulnerability on the HIV-1 envelope (Env) glycoprotein (gp) complex that mediates viral entry into cells (refs. 1-6 and reviewed in refs. 7-11). Passive immunization studies show that sterilizing immunity can be achieved if sufficient amounts of bnAbs are present before virus challenge in macaques (12-16). Hence, intensive efforts are ongoing to design immunogens capable of re-eliciting these types of bnAbs by vaccination.
PG9 is the founder member of an expanding family of glycandependent human antibodies that preferentially bind the HIV (HIV-1) envelope (Env) glycoprotein (gp) trimer and broadly neutralize the virus. Here, we show that a soluble SOSIP.664 gp140 trimer constructed from the Clade A BG505 sequence binds PG9 with high affinity (∼11 nM), enabling structural and biophysical characterizations of the PG9:Env trimer complex. The BG505 SOSIP.664 gp140 trimer is remarkably stable as assessed by electron microscopy (EM) and differential scanning calorimetry. EM, small angle X-ray scattering, size exclusion chromatography with inline multiangle light scattering and isothermal titration calorimetry all indicate that only a single PG9 fragment antigen-binding (Fab) binds to the Env trimer. An ∼18 Å EM reconstruction demonstrates that PG9 recognizes the trimer asymmetrically at its apex via contact with two of the three gp120 protomers, possibly contributing to its reported preference for a quaternary epitope. Molecular modeling and isothermal titration calorimetry binding experiments with an engineered PG9 mutant suggest that, in addition to the N156 and N160 glycan interactions observed in crystal structures of PG9 with a scaffolded V1/V2 domain, PG9 makes secondary interactions with an N160 glycan from an adjacent gp120 protomer in the antibody-trimer complex. Together, these structural and biophysical findings should facilitate the design of HIV-1 immunogens that possess all elements of the quaternary PG9 epitope required to induce broadly neutralizing antibodies against this region. R ational immunogen design is an increasingly promising approach for development of an effective human immunodeficiency virus-1 (HIV-1) vaccine. The recent discovery of many new and potent broadly neutralizing antibodies (bnAbs) has helped define conserved sites of vulnerability on the HIV-1 envelope (Env) glycoprotein (gp) complex that mediates viral entry into cells (refs. 1-6 and reviewed in refs. [7] [8] [9] [10] [11] . Passive immunization studies show that sterilizing immunity can be achieved if sufficient amounts of bnAbs are present before virus challenge in macaques (12) (13) (14) (15) (16) . Hence, intensive efforts are ongoing to design immunogens capable of re-eliciting these types of bnAbs by vaccination.
The major difficulty in mounting an effective antibody response against HIV-1 resides in the multiple evasion strategies that have evolved in Env. An error-prone reverse transcriptase drives a high degree of Env sequence diversity (17) (18) (19) . The few conserved regions of Env are shielded by an extensive array of glycans (20) (21) (22) (23) (24) and are often occluded by more variable structures, such as the V1-V5 loops. However, because some HIV-1-infected individuals can develop bnAbs over the course of infection, these various evasion strategies are not insurmountable (1, (25) (26) (27) . Although bnAbs do not seem to confer significant protection against disease progression in infected individuals (28, 29) , their induction through vaccination might prevent the acquisition of infection. Thus, the epitopes recognized by bnAbs are now being carefully scrutinized to serve as templates for rational vaccine design.
Conserved elements in the V1/V2 variable loops on gp120 contain epitopes for a family of glycan-dependent bnAbs, including PG9 and PG16. These quaternary-preferring bnAbs were isolated from an African donor and neutralize 70-80% of circulating HIV-1 isolates with high potency (2, 6) . Both antibodies possess an elongated (28 residues), hammerhead-shaped, complementaritydetermining region 3 of the heavy chain (HCDR3) that contains tyrosine sulfation sites (30, 31) . Other bnAbs that target the same epitopes in this region, such as the PGT140 and CH01 series, share both of these unusual structural features (6, 32) . Whether other V1/V2 bnAbs have similar characteristics is as yet unclear (33) . Early functional studies showed that the interaction between PG9 or PG16 and the V1/V2 loop highly depends on a glycan at position N160 and the overall cationic character of protein segments in this region (2) . Recently, cocrystal structures of protein scaffolds bearing V1/V2 loops from two different isolates showed that PG9 interacts with two glycans and a β-strand (32). More specifically, the HCDR3 hammerhead penetrates the glycan shield to mediate mostly charged interactions with strand C of a disulfide-linked, antiparallel β-sheet in the V1/ V2 region, whereas glycans at positions N160 and either N156 or N173 are accommodated in the surrounding antibody paratope (32) . Although these structures clearly revealed some of the key interactions between PG9 and the V1/V2 loops at an atomic level, they did not clarify why bnAbs in this family are generally trimerspecific (i.e., why they do not bind to most monomeric gp120 proteins, despite neutralizing the corresponding virus).
Here, we elucidate how PG9 recognizes soluble Env trimers. These trimers are based on the BG505 Clade A sequence, cleaved at the gp120/gp41 junction, stabilized by SOSIP mutations, and truncated at residue 664 of the gp41 ectodomain (34) (35) (36) (37) . Several biochemical and biophysical techniques, alone and in combination, clearly show that only a single PG9 fragment antigen-binding (Fab) binds each BG505 SOSIP.664 glycoprotein 140 (gp140) trimer. Overall, these findings may have significant implications for guiding immunogen design efforts intended to induce PG9-like bnAbs by vaccination; it now seems important to display all of the components of these quaternary epitopes in an appropriate, sterically constrained setting. Finally, the BG505 SOSIP.664 gp140 trimers have stability and antigenicity properties that might render them suitable for immunogen development and further structural studies.
Results

Purification of a PG9:HIV-1 Trimer Complex and Initial Biophysical
Characterization. Recombinantly produced PG9 Fab was added in molar excess to cleaved BG505 SOSIP.664 gp140 trimers produced in 293S GnT I-deficient cells. During size exclusion chromatography (SEC) on a Superose 6 10/30 column, the PG9 Fab:trimer complex eluted slightly earlier (14.3 mL) than the corresponding unliganded trimer (14.7 mL) ( Fig. 1 A and B) . Nonreducing denaturing gel electrophoresis (SDS/PAGE) analysis of the eluted samples showed that PG9 bound to the trimer in a ratio of one Fab to three gp140 protomers (Fig. 1C) . SEC with multiangle light scattering (SEC-MALS) showed that the glycoprotein molar mass (MM glycoprotein ) of the eluted Fab:trimer complex was monodisperse and ∼387 kDa (Fig. 1B and Table S1 ); the observed mass again corresponded, within experimental error, to one PG9 Fab bound per trimer (Fig. 1B and Table S1 ). The SEC-purified PG9 Fab:trimer complex was not able to bind additional PG9 IgG in immunoprecipitation assays (Fig. S1) . Together, these biophysical data hinted at a unique mode of HIV-1 Env recognition in which a single PG9 Fab binds to the Env trimer and suggested that the complex was amenable to structural characterization.
Molecular Structure Revealed by Small Angle X-Ray Scattering. X-ray scattering measurements were made on the purified PG9 Fab: trimer complex at three different concentrations. In-depth analysis of the small angle X-ray scattering (SAXS) data revealed that the samples were almost entirely free of aggregation and properly folded, and that individual scattering particles were not significantly interacting with one another (Fig. S2) . The excluded volume determined by analysis of the Porod invariant was 786 nm 3 ( Fig. S2 ). This volume is directly related to molecular mass by a factor of 0.5 for large globular proteins (38) , so the implied mass of the Fab:trimer complex is ∼393 kDa. Hence, the SAXSdetermined molecular mass of the monodisperse sample, which has a theoretical calculated mass of 392 kDa (Table S1 ), corroborated the SEC-MALS data and provided further evidence that only one PG9 Fab binds to each Env trimer. An ab initio density map was generated from scattering data with q max = 0.2 Å −1 that corresponds to a ∼30 Å nominal resolution for the scattering curve (38) . The resulting low-resolution density map allowed the previously determined crystal structure of monomeric gp120 to be fitted into a trimeric arrangement and the crystal structure of a complex containing one PG9 Fab and gp120 V1/V2 scaffold ( Fig. 2A ).
Molecular Structure Revealed by Negative Stain Single Particle EM.
The interaction between the PG9 Fab and the SOSIP.664 gp140 trimer was also analyzed by negative stain electron microscopy (EM). The reference free 2D class averages of a purified complex, and an unpurified sample containing a 10-fold molar excess of the Fab, unequivocally showed that the Fab recognizes the trimer in a unique and asymmetric manner (Figs. S3 and S4 and Table S2 ); the interaction is dissimilar to those for all other structurally characterized bnAbs, where one Fab is bound to each gp120 protomer in a threefold symmetric arrangement (39) (40) (41) . In addition to corroborating the low-resolution SAXS solution structure (Fig. S5) , the EM reconstruction enabled highfidelity docking of the PG9:V1/V2 scaffold crystal structure ( Fig.  2B and Fig. S6 ). In the fitted model, the PG9 HCDR3 hammerhead sits directly atop the trimer and the N160 glycan lies immediately adjacent to the trimer axis, whereas the glycan at positions N156 or N173 resides at the outer edge of the density ascribed to V1/V2 (Fig. 2B ). One copy of core gp120 can be fitted into each of the three lobes of density that correspond to each protomer of the Env trimer. Two of these gp120 protomers were positioned in close proximity to PG9, whereas the third appears to have moved away from the trimer center, explaining the loss of C3 symmetry (Fig. 2C ). This observation led to the hypothesis that the preference of PG9 for a quaternary epitope might be attributable to additional interactions involving one or Table S1 . (C) Nonreducing SDS/PAGE gel analysis of the eluting SEC fractions. PG9 Fab and BG505 SOSIP.664 were stained similarly in control lanes when the same amount of protein was used. ImageJ (59) was used to determine that, in the eluting samples, one PG9 Fab associates with three gp140 moieties (1:3 ratio).
both of the other two V1/V2 loop structures that are also present at the trimer apex. A secondary interaction site of this nature could not have been observed in the PG9:V1/V2 scaffold crystal structure, which involves only monomeric components.
High-Affinity PG9 Binding and a Putative Secondary Site of Interaction on the Env Trimer. Fitting the PG9:V1/V2 crystal structure into the EM reconstruction suggested that the PG9 Fab made additional trimer contacts via its HCDR1, HCDR3, and complementary determining region 2 of the light chain (LCDR2) regions. To probe whether this element of the PG9 binding site interacts with a different V1/V2 moiety at the trimer interface, a PG9 mutant was designed. A bulky Man 5 GlcNAc 2 glycan was introduced into PG9 to interact with the pocket around the predicted secondary V1/V2 interaction by substituting residues 56 SGV 58 at the edge of LCDR2 with a canonical NGT glycosylation motif (Fig. 3A) . This strategy enabled contacts or steric clashes lying within the ∼16 Å × 14 Å × 10 Å footprint of the Man 5 GlcNAc 2 glycan to be probed by assessing changes to antibody function. Accordingly, when tested in HIV-1 neutralization assays, the glycan mutant of PG9 was ∼10-fold less potent than the WT antibody (Fig. 3B) . Of note is that the WT and glycan-mutant forms of PG9 bound to monomeric BG505 gp120 with almost identical affinities (∼20-30 nM), as assessed by isothermal titration calorimetry (ITC), but the glycan mutation caused a >10-fold reduction in the Fab affinity for the BG505 SOSIP.664 gp140 trimer (Fig. 3C and Table S3 ). Thus, the introduced glycan moiety has quantitatively similar adverse effects on both trimer binding and virus neutralization. Together, these results indicate that PG9 LCDR2, the site of the introduced The EM reconstruction of the unliganded BG505 SOSIP.664 gp140 trimer showed a slightly more compact structure than the corresponding unliganded trimer based on the KNH1144 sequence (34) (Fig. 4A and Fig. S7 ). In accord with these structural observations, the melting temperature of these two constructs (Tm), as probed by differential scanning calorimetry (DSC), differed significantly. Whereas the KNH1144 gp140 trimer showed thermal transitions at three different temperatures (51.3°C, 61.4°C, and 68.1°C), its BG505 counterpart remained intact up to a temperature of 67.9°C (Fig. 4B) . These data imply that the BG505 SOSIP.664 gp140 trimer is unusually stable; overall, we saw no signs of subunit dissociation until complete protein unfolding occurs. Of additional note is that PG9 binding appears to have both (C) EM reconstruction with low (light purple) and high (dark purple) contour levels demonstrating the asymmetry of the complex and how PG9 recognizes two gp120 protomers of the Env trimer. For comparison, a reconstruction of the unliganded BG505 SOSIP.664 trimer is displayed in the mesh. The red, blue, and yellow dots are used to portray the edges of the three different gp120 protomers. Images were generated with UCSF Chimera (58). Fig. 2 with, in addition, the PG9 HCDRs and LCDRs now depicted in shades of green and red, respectively. This image was generated with UCSF Chimera (58) . (B) WT PG9 (IC 50 = 0.0038 μg/mL) is ∼10-fold more potent than the LC glycan mutant (IC 50 = 0.031 μg/mL) at neutralizing the BG505 pseudovirus.
BG505 gp120 monomer +PG9 WT
(C) Representative raw data and isotherms of multiple ITC experiments show that, whereas the PG9 LC glycan mutant binds to the BG505 gp120 monomer with the same affinity as PG9 WT, it has a >10-fold lower binding affinity for the corresponding SOSIP.664 gp140 trimer. Thermodynamic parameters of binding are summarized in Table S3 .
a destabilizing and a stabilizing effect on the BG505 SOSIP.664 gp140 trimer. Upon PG9 binding to the trimer, two thermal transitions at 52.2°C and 73.8°C (Fig. 4C ) occur in addition to those seen with the individual unbound PG9 Fab and trimer components ( Fig. 4B and Fig. S8 ). The thermal stability profile of the BG505 SOSIP.664 gp140 trimer contrasts with the destabilizing effect of soluble CD4 binding (Fig. 4C ) and is consistent with other studies where soluble CD4-induced conformational changes in trimers are reported to drive conversion to a more open conformation (42) . Our DSC data therefore support a mechanism by which PG9 binding stabilizes two of the gp120 protomers in the trimer (those to which it binds), while destabilizing the third protomer that, as a consequence, disrupts the overall integrity of the trimer.
Role of Glycosylation in PG9 Recognition of Env. Expression of glycoproteins in 293S cells, in which glycan maturation pathways are blocked, leads to an accumulation of unprocessed, high-mannose sugars (43, 44) . However, 293T cells can process immature glycans to complex forms. EM data confirmed that one PG9 binds to the trimer in a similar asymmetric manner whether the trimer is produced in 293S or 293T cells (Fig. S4) . However, we saw marked differences in the affinities of PG9 for monomeric gp120 and trimeric gp140, depending on the expression system used. PG9 WT had similar (∼30 nM) binding affinities for the SOSIP.664 gp140 trimer and gp120 monomer from 293S cells, but the antibody bound with much higher affinity to the trimer (11 nM) than to the corresponding monomer (110 nM), when both Env proteins were produced in 293T cells (Fig. S9) . The proximity of additional PG9 components, such as HCDR1, HCDR3, and LCDR2, to elements located at the trimer apex appears to create a higher affinity interaction when the SOSIP.664 gp140 trimers are produced in 293T cells. These data imply that specific glycoforms on the Env trimer, which may include complex and high mannose sugars, are important components of the complete PG9 epitope.
Discussion
It was shown that the PG9 bnAb is directed against an epitope in the V1/V2 region of gp120 (2, 32 For clarity, the third gp120 protomer has been omitted. PG9 (shades of gray) sits directly above the trimer axis and potentially accommodates additional elements to those previously identified in the PG9:V1/V2 crystal structures, such as a second N160 Man 5 GlcNAc 2 glycan. The model on the left was generated from the EM reconstruction of the unliganded membrane-anchored HIV-1 Env trimer (blue mesh, Electron Microscopy Data Bank ID codes 5019 and 5021) (40) with modeled glycans and the PG9 Fab shown as blue spheres and a gray surface, respectively. The colors and rendering of Inset are as used in Figs. 2 and 3 . A second V1/V2 model (purple) with ∼120°rotation relative to the primary V1/V2 model (magenta) was generated to fit the density. Images were generated with UCSF Chimera (58).
(B) Cartoon representation of the PG9 epitope on the Env trimer, showing the N156 glycan (yellow), the N160 glycan (magenta), cationic elements of strand C (cyan) from the first V1/V2 gp120 protomer, and the suggested involvement of a second N160 glycan (purple) from a neighboring protomer.
(C) Cartoon representation of how the interaction of PG9 with two V1/V2 elements at the Env trimer apex results in the third gp120 protomer slightly peeling away from the trimer axis. Glycans are shown as spheres, gp41 as orange rectangles, whereas other elements are colored as in previous figures.
a single PG9 Fab interacts asymmetrically with the Env trimer with nanomolar binding affinity and appears to engage two V1/ V2 elements at the trimer apex. Overall, our EM, neutralization, and binding data indicate that PG9 has a more extended site of interaction with the trimer than was revealed by the crystal structure of the monomeric PG9:V1/V2 scaffold complex (32) . Elements of the extended paratopes, including HCDR1, HCDR3, and LCDR2, come into close proximity to a neighboring V1/V2 moiety at the trimer apex; these secondary interactions appear to involve the glycan moiety located at position N160. In the context of the Env trimer, PG9 could, therefore, contact a total of three glycans and a β-strand (Fig. 5) . The additional protein and glycan elements emanating from a neighboring protomer may, wholly or in part, explain the previously reported quaternary nature of the PG9 epitope (2) . Thus, the PG9:BG505 SOSIP.664 gp140 trimer structure reported here represents a paradigm shift in antibody recognition of HIV-1 Env, where only a single Fab binds to the Env trimer by interacting asymmetrically with two of the three gp120 protomers. Previous mixed-trimer neutralization experiments led to the hypothesis that PG9 recognized a single protomer of a trimer (2, 43) , but that test system could not detect the weaker secondary interactions that we deduce from structural studies.
Our EM-derived model suggests that the N160 glycans from each protomer are arranged at the Env apex in close proximity to one another around the threefold axis (Fig. S10) . We postulate that the elongated anionic, tyrosine-sulfated HCDR3 hammerhead of PG9 penetrates through a dense trimeric cluster of N160 and N156/173 glycans to reach a secluded cationic groove in the center of the trimer atop the spike (Fig. 5) . PG9 recognition of its quaternary epitope at the Env trimer apex represents a unique asymmetric binding mode when compared to other HIV-1 bnAbs or any other viral glycoprotein-antibody complex. Although additional work is needed to confirm the exact carbohydrate glycoform(s) present at the interacting N-glycosylation sites, steric constraints imposed by gp120 trimerization would restrict processing of the glycans that are located in this region near the trimer apex (45) (46) (47) . Our comparative studies of BG505 gp120 and SOSIP.664 gp140 trimers expressed in 293S vs. 293T cells suggest that the precise glycoforms in and around the PG9 epitope influence binding affinity, but not the binding mode. Future studies on deciphering the exact glycan composition at these interacting sites in monomers and trimers in different cell types, and how differential glycosylation correlates with antigenicity, is likely to be very informative.
To date, only a few gp120 monomers, from clones such as BG505, have been shown to bind PG9, for reasons that have been poorly understood (31, 32, 36, 43, 48, 49) . It is likely that the PG9 epitope on these select monomers is broadly similar to, but also critically different from, the bona fide epitope present on the native Env trimer. Glycoform profiles may be particularly important in this regard; although the BG505 gp120 monomer binds PG9, the gp120 has to be produced in a cell line (293S) that yields proteins with an artificially high mannose content for the affinity to reach the nanomolar range. When the same gp120 is made in 293T cells, it has a lower affinity for PG9 and only a small fraction is competent for binding. We suggest that, for most other gp120 monomers, these glycan-dependent restrictions on the formation of the PG9 epitope are more profound, leading to significantly reduced or no affinity. Additionally, in the context of the trimer, the V1/V2 loops may be constrained in a particular orientation that is not generally exhibited in the monomer.
We hypothesize that the bona fide (i.e., high affinity) form of the PG9 epitope is present only on properly folded trimers and absent from nonfunctional, but highly immunogenic, forms of Env also present on virions. Accordingly, such a quaternary epitope might elicit a particularly productive response from the host's humoral immune system. Here, we show that the BG505 SOSIP.664 gp140 trimer not only binds PG9, but is also more thermally stable than gp120 monomers (50, 51) and previously described SOSIP gp140 trimers (34) . Studies comparing how neutralizing and nonneutralizing Abs recognize the CD4bs on Env highlight the importance of epitope presentation in the context of the functional trimer (50) . Thus, this Env trimer may be useful in a vaccine context for presentation of quaternary and other broadly neutralizing epitopes that are now being defined from analyses of bnAbs generated during the course of natural HIV-1 infection.
Materials and Methods
The PG9 Fab, BG505 gp120 monomer, and BG505 SOSIP.664 gp140 trimer were expressed as recombinant proteins and purified as described (31, 34, 41) . Melting temperatures of trimers and Fab:trimer complexes were measured by DSC, whereas PG9 Fab binding to Env proteins was assessed by SEC-MALS, ITC, SAXS, and EM. The SAXS data were analyzed by using PRIMUS (52), GASBOR (53) , and DAMAVER (54) . EM reconstructions were carried out by using Xmipp (55), IMAGIC (55), SPARX (56) , and EMAN (57) . Fitting of X-ray models into the EM reconstruction was carried out by using UCSF Chimera (58) . For more details, see SI Materials and Methods. 
